Beam Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +6,853.0% | -6.5% | +189.4% | +226.4% | -9.0% | +8.8% | -24.4% | +34.2% | |
| – | +7,179.1% | -36.2% | +226.1% | +312.9% | -14.1% | +10.8% | -27.5% | +44.5% | |
| – | +7,603.5% | -74.6% | +335.7% | +245.3% | -58.4% | +87.3% | -35.3% | +4.6% | |
| – | +7,603.5% | -37.3% | +226.3% | +222.2% | +11.6% | +10.4% | -28.5% | +46.4% | |
| – | – | – | – | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +155.2% | +189.9% | +49.1% | +25.2% | – | – | – | |
| – | +400.9% | +67.2% | +273.7% | +214.2% | -6.1% | -21.3% | -22.6% | -34.4% | |
| – | +289.7% | +13.9% | +251.2% | +108.6% | +4.8% | -8.1% | -11.4% | -46.8% | |
| – | – | – | +12.3% | +55.1% | +5.6% | +23.1% | +5.4% | +6.6% | |
| – | +912.5% | +6.7% | -19.5% | +18.4% | +20.8% | -82.1% | +139.4% | +164.3% | |
| – | – | – | +20.0% | -43.2% | – | – | – | – | |
| – | – | -24.7% | +143.3% | +236.7% | -11.3% | +33.8% | -25.2% | +68.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +171.3% | +46.1% | -9.0% | +37.4% | +9.0% | +10.2% | +6.7% | +20.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.